ACCSAP, CathSAP, EP SAP, and HF SAP will be unavailable Jan. 28 - Feb. 2.

Pierluigi Tricoci, MD, MHS, PHD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Merck(MODEST), CSL Behring (MODEST) RESEARCH/RESEARCH GRANTS: Merck(SIGNIFICANT), Regenraon(SIGNIFICANT), Sanofi-Aventis(SIGNIFICANT), CSL Behring (SIGNIFICANT), Amgen Inc.(SIGNIFICANT)

View Full Disclosure